Schedule Dispatches

Kia ora

This is an early notification of the changes to be announced in the Update to the Pharmaceutical Schedule.

The full Update will be available as a PDF on our website.(external link)

The changes will be published in the online Schedule around the 23^rd of this month and are effective from next month.

For any questions about these listing changes or the Pharmaceutical Schedule in general, email us at enquiry@pharmac.govt.nz.

August 2024

New Listings

• Adrenaline (Hameln) inj 1 in 1,000, 1 ml ampoule – Up to 5 inj available on a PSO, s29 and wastage claimable (p’code 2685043)
• Aminoacid formula without isoleucine, methionine, threonine and valine (MMA/PA Anamix Infant) powder can, 400 g OP – Special Authority – Hospital pharmacy [HP3] (p’code 2386313)
• Aminoacid formula without lysine powder, can, 400 g OP (GA Anamix Infant) (p’code 2400480) and powder (neutral), 18 g sachets (GA Anamix Junior) (p’code 2498820) – Special Authority – Hospital pharmacy [HP3]
• Amino acid formula without methionine, threonine and valine (MMA/PA Anamix Junior) powder (neutral), 18 g sachets – Special Authority – Hospital pharmacy [HP3] (p’code 2498812)
• Aminoacid formula without methionine powder (unflavoured), can, 400 g OP (HCU Anamix Infant) (p’code 2682982); powder (neutral) 36 g sachets (HCU Anamix Junior) (p’code 2682990); liquid (orange) 125 ml bottles (HCU Anamix Junior LQ) (p’code 2683008) and liquid (juicy berries) 125 ml bottles (HCU Lophlex LQ) (p’code 2592096) – Special Authority – Hospital pharmacy [HP3]
• Aminoacid formula without phenylalanine and tyrosine powder (neutral) 36 g sachets (TYR Anamix Junior) (p’code 2432102); powder, can, 400 g OP (TYR Anamix Infant) (p’code 2405342); liquid (orange) 125 ml bottle (TYR Anamix Junior LQ) (p’code 2683024) and liquid (juicy berries) 125 ml pouches (TYR Lophlex LQ 20) (p’code 2610906) – Special Authority – Hospital pharmacy [HP3]
• Aminoacid formula without phenylalanine (PKU First Spoon) powder (unflavoured) 12.5 g sachets – Special Authority – Hospital pharmacy [HP3] (p’code 2682966)
• Aminoacid formula without valine, leucine and isoleucine powder (unflavoured), can, 400 g OP (MSUD Anamix Infant) (p’code 2184257); powder (neutral) 36 g sachets (MSUD Anamix Junior) (p’code 2528649); liquid (orange) 125 ml bottles (MSUD Anamix Junior LQ) (p’code 2637413) and liquid (juicy berries) 125 ml pouches (MSUD Lophlex LQ 20) (p’code 2683016) – Special Authority – Hospital pharmacy [HP3]
• Bimatoprost (Lumigan) eye drops 0.03%, 3 ml OP (p’code 2109220)
• Calcium folinate (Eurofolic) inj 10 mg per ml, 100 ml vial – PCT only – Specialist, s29 (p’code 2687364)
• Capsaicin (Zo-Rub Osteo) crm 0.025%, 45 g OP – Special Authority – Retail pharmacy and s29 (p’code 2682885)
• Capsaicin (Zo-Rub HP) crm 0.075%, 45 g OP – subsidy by endorsement and s29 (p’code 2682893)
• Clonidine hydrochloride (Catapres) inj 150 mcg per ml, 1 ml ampoule (p’code 202266)
• Elemental feed with high medium chain triglycerides (Emsogen) powder (neutral), 100 g sachets – Special Authority – Hospital pharmacy [HP3] (p’code 2508419)
• Essential amino acid formula (Essential Amino acid Mix) powder (neutral), can, 200 g OP – Special Authority – Hospital pharmacy [HP3] (p’code 2389053)
• Glycomacropeptide and amino acid contains some phenylalanine powder (vanilla) 33.4 g sachets (PKU GMPro 20 Vanilla) (p’code 2682931); powder (unflavoured) 12.5 g sachets (PKU GMPro Mix-In) (p’code 2682958) and liquid (neutral), 250 ml carton (PKU GMPro LQ) (p’code 2682974) – Special Authority – Hospital pharmacy [HP3]
• Ipratropium bromide (Pharmascience) nebuliser soln, 250 mcg per ml, 2 ml ampoule – Up to 40 neb available on a PSO, s29 and wastage claimable (p’code 2687070)
• Lenalidomide (Viatris) (Lenalidomide Viatris) cap 5 mg (p’code 2673525), 10 mg (p’code 2673533), 15 mg (p’code 2673541) and 25 mg (p’code 2673568) – Special Authority – Retail pharmacy
• Naphazoline hydrochloride (Albalon) eye drops 0.1%, 15 ml OP (p’code 200182)
• Octreotide (Omega) inj 100 mcg per ml, 1 ml vial – s29 and wastage claimable (p’code 2687275)
• Pharmacy services (BSF Noumed Phenobarbitone) brand switch fee – may only be claimed once per patient (p’code 2684756)
• Pomalidomide (Pomolide) cap 1 mg, 14 cap pack (p’code 2680297) and 21 cap pack (p’code 2680300); cap 2 mg, 14 cap pack (p’code 2680319) and 21 cap pack (p’code 2680327); cap 3 mg, 14 cap pack (p’code 2680335) and 21 cap pack (p’code 2680343) and cap 4 mg, 14 cap pack (p’code 2680351) and 21 cap pack (p’code 2680378) – Special Authority – Retail pharmacy
• Protein free supplement containing carbohydrate, fat with added vitamins and minerals (Energivit) powder (neutral), can, 400 g OP – Special Authority – Hospital pharmacy HP3] (p’code 2000628)

Changes to restrictions, chemical names and presentations

• Aminoacid formula without methionine (XMET Maxamum) powder (neutral), can, 500 g OP – amended presentation description
• Aminoacid formula without valine, leucine and isoleucine (MSUD Maxamum) powder (neutral), can, 500 g OP – amended presentation description
• Bortezomib inj 3.5 mg vial (DBL Bortezomib) and inj 1 mg for ECP (Baxter) – amended Special Authority criteria
• Diphtheria, tetanus, pertussis, polio, hepatitis B and haemophilus influenzae type B vaccine (Infanrix-hexa) inj 30IU diphtheria with 40IU tetanus and 25mcg pertussis toxoids, 25mcg pertussis filamentous haemagglutinin, 8mcg pertactin, 80D-AgU polio virus, 10mcg hepatitis B antigen, 10mcg H. influenzae type b with tetanus toxoid 20-40mcg in 0.5ml syringe – amended restriction criteria
• Foods And Supplements for Inherited Metabolic Disease – amended Special Authority criteria
• Hepatitis B recombinant vaccine (Engerix-B) inj 10 mcg per 0.5 ml prefilled syringe and inj 20 mcg per 1 ml prefilled syringe – amended restriction criteria
• Lenalidomide (Revlimid) cap 5 mg, 10 mg, 15 mg and 25 mg – amended chemical name
• Nicorandil (Max Health) tab 10 mg and 20 mg – removal of brand switch fee
• Oxycodone hydrochloride (Oxycodone Amneal) tab immediate-release 5 mg, 10 mg and 20 mg – removal of s29 and wastage claimable
• Phenobarbitone (Noumed Phenobarbitone) tab 15 mg – addition of brand switch fee
• Thalidomide (Thalomid) cap 50 mg and 100 mg – amended Special Authority criteria

Increased subsidy

Chemical	Presentation	Fully subsidised brands
Aminoacid formula without methionine	Powder (neutral), can, 500 g OP	XMET Maxamum
Aminoacid formula without valine, leucine and isoleucine	Powder (neutral), can, 500 g OP	MSUD Maxamum
Amoxicillin with clavulanic acid	Grans for oral liq amoxicillin 50 mg with clavulanic acid 12.5 mg per ml, 100 ml OP	Curam
Cisplatin	Inj 1 mg for ECP	Baxter
Midazolam	Inj 1 mg per ml, 5 ml ampoule	Midazolam-Baxter
Pentoxifylline [oxpentifylline]	Tab 400 mg	Trental 400
Pericyazine	Tab 2.5 mg and 10 mg	Neulactil

Decreased subsidy

Chemical	Presentation	Fully subsidised brands
Aprepitant	Cap 2 × 80 mg and 1 × 125 mg, 3 OP	Emend Tri-Pack
Bosentan	Tab 62.5 mg and 125 mg	Bosentan Dr Reddy’s
Midazolam	Inj 5 mg per ml, 3 ml ampoule	Midazolam-Baxter